Corpus 1,272 assessed · 1,173 scored · 643 reproduced ≥75 · 168 flagged ·∅ 74.1/100

Publications 2 Datasets 392.5k Experiments 4.7k

Explore

Filters: BMC Cancer ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
Integrating multi-omics data reveals the antitumor role and clinical benefits of gamma-delta T cells in triple-negative breast cancer. PMID 40197136	BMC Cancer	2025	59	L1 59/100
Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel. PMID 33138797	BMC Cancer	2020	72	L1 72/100

Integrating multi-omics data reveals the antitumor role and clinical benefits of gamma-delta T cells in triple-negative breast cancer.

PMID 40197136 · BMC Cancer · 2025

L1 59/100

Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel.

PMID 33138797 · BMC Cancer · 2020

L1 72/100